Benefits reported by MEDVi patients include: Losing an average of 15-20% of total body weight Experiencing fewer cravings and stronger appetite control Improved mood, energy levels, and sleep quality High patient satisfaction, with 9 out of 10 calling it the most effective treatment they have tried Long-term success, with 93% maintaining their results after six months GLP-1 therapy is more than a weight loss tool
The phase 2 type 2 diabetes trial also reported dose-dependent bodyweight decreases at 36 weeks, including 16.94% in the 12 mg group versus 3.00% with placebo [5]
This was sitting in a room temperature, was on a shelf, in the hot and cold weather, everything
Dutta D et al
Here is how to approach this the right way
Most current users inject AOD-9604 rather than taking it orally, so the trial data may underestimate what injectable protocols achieve